PSNL MRK Personalis (NASDAQ: PSNL) has attracted takeover interest from Pharmaceutical giant Merck (NYSE: MRK) and at least two other suitor
PSNL MRK Personalis (NASDAQ: PSNL) has attracted takeover interest from Pharmaceutical giant Merck (NYSE: MRK) and at least two other suitors, according to a source. As a result of the overtures, the Precision Oncology company is said to have hired Bankers at Centerview and TD Securities and legal counsel at Cooley to review a potential sale of the company.
PSNL MRK Personalis (NASDAQ: PSNL) has attracted takeover interest from Pharmaceutical giant Merck (NYSE: MRK) and at least two other suitors, according to a source.
As a result of the overtures, the Precision Oncology company is said to have hired Bankers at Centerview and TD Securities and legal counsel at Cooley to review a potential sale of the company.